Closing of the Sale of the Total Stake of Technogenetics Srl, previously controlled by Bouty SpA (this latter controlled by the Swiss group IBSA) to KHB Shanghai Kehua Bio-engineering Co. Ltd. Once purchased by KHB, Technogenetics Srl passed under control of a NewCo called Technogenetics Holding Srl, where Altergon Italy also transferred its in vitro diagnostic activities as well as its R&D activities in Italy and in China (Qingdao and Shenzhen).